BioSpace News Archive

Business

Misonix to Report Fiscal 2020 Third Quarter Financial Results and Host Conference Call and Webcast on May 11

Misonix, Inc., a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, announced that it will report its fiscal 2020 third quarter financial results after the market closes on Monday, May 11, 2020.

May 6, 2020
·
1 min read
FDA

FDA Approves First Targeted Therapy to Treat Aggressive Form of Lung Cancer

The U.S. Food and Drug Administration approved Tabrecta for the treatment of adult patients with non-small cell lung cancer that has spread to other parts of the body.

May 6, 2020
·
5 min read
Business

Evolus to Report First Quarter 2020 Financial Results and Provide a Business Update on Monday, May 11, 2020

Evolus, Inc., a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced that it will report its first quarter 2020 financial results and provide a business update on Monday, May 11, 2020 after the close of the U.S. financial markets.

May 6, 2020
·
1 min read
Business

TRACON to Report First Quarter 2020 Financial Results and Company Highlights on May 13, 2020

TRACON Pharmaceuticals announced that it will report its first quarter 2020 financial and operating results after the close of U.S. financial markets on Wednesday, May 13, 2020.

May 6, 2020
·
1 min read
Business

AnaptysBio Announces First Quarter 2020 Financial Results and Provides Pipeline Updates

Interim Top-Line Data From Etokimab ECLIPSE Phase 2 Trial in Chronic Rhinosinusitis with Nasal Polyps Anticipated in Third Quarter of 2020, Decided to Over-Enroll Trial Due to COVID-19

May 6, 2020
·
10 min read
Business

SeaSpine Reports First Quarter 2020 Financial Results

SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced financial results for the three-months ended March 31, 2020.

May 6, 2020
·
8 min read
Business

Sarepta Therapeutics Announces First Quarter 2020 Financial Results and Recent Corporate Developments

Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, reported financial results for the three months ended March 31, 2020.

May 6, 2020
·
25 min read
Business

Morphic Announces Corporate Highlights and First Quarter 2020 Financial Results

Morphic Therapeutic, a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, reported corporate highlights and first quarter 2020 financial results.

May 6, 2020
·
6 min read
Business

BioTelemetry, Inc. Reports First Quarter 2020 Financial ResultsAnnounces Record Quarterly Revenue

BioTelemetry, Inc., the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, reported results for the quarter ended March 31, 2020.

May 6, 2020
·
9 min read
Business

Axogen, Inc. Reports First Quarter 2020 Financial Results

Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, reported financial results and business highlights for the first quarter ended March 31, 2020.

May 6, 2020
·
16 min read